17 alpha-hydroxyprogesterone caproate and Abnormalities, Urogenital

17 alpha-hydroxyprogesterone caproate has been researched along with Abnormalities, Urogenital in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Abdalla, A; Dotters-Katz, SK; Hynes, JS; Manuck, TA; Schwartz, AR	1
Azimi, S; Bohec, C; Bretelle, F; Capelle, M; Connan, L; Deruelle, P; Langer, B; Perrotin, F; Porcher, R; Rozenberg, P; Senat, MV; Vayssière, C; Winer, N	1
Abdul Karim, AK; Lim, PS; Ng, BK; Ng, KS; Omar, MH; Shafiee, MN	1

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Abnormalities, Urogenital

Article	Year
17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. American journal of obstetrics and gynecology, 2015, Volume: 212, Issue:4 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydroxyprogesterones; Injections, Intramuscular; Intention to Treat Analysis; Pregnancy; Premature Birth; Prenatal Care; Progestins; Proportional Hazards Models; Risk Factors; Treatment Outcome; Urogenital Abnormalities; Uterine Cervical Incompetence; Uterus	2015

Article

Year

17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.

American journal of obstetrics and gynecology, 2015, Volume: 212, Issue:4

Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydroxyprogesterones; Injections, Intramuscular; Intention to Treat Analysis; Pregnancy; Premature Birth; Prenatal Care; Progestins; Proportional Hazards Models; Risk Factors; Treatment Outcome; Urogenital Abnormalities; Uterine Cervical Incompetence; Uterus

2015

Other Studies

2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Abnormalities, Urogenital

Article	Year
17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth? American journal of obstetrics & gynecology MFM, 2021, Volume: 3, Issue:1 Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Urogenital Abnormalities; Uterus	2021
Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report. Hormone molecular biology and clinical investigation, 2016, Sep-01, Volume: 27, Issue:3 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Progestins; Urogenital Abnormalities; Uterus	2016

Article

Year

17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

American journal of obstetrics & gynecology MFM, 2021, Volume: 3, Issue:1

Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Urogenital Abnormalities; Uterus

2021

Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.

Hormone molecular biology and clinical investigation, 2016, Sep-01, Volume: 27, Issue:3

Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Progestins; Urogenital Abnormalities; Uterus

2016